ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
-0,61%
Dow Jones
39 671,04
-0,51%
DAX
18 680,20
-0,25%
Brent Oil
81,17
-0,44%
Bitcoin
69 411,82
0,45%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) Actualités

FOLD Amicus Therapeutics Inc

9,72
-0,19 (-1,92%)
23 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Amicus Therapeutics Inc FOLD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,19 -1,92% 9,72 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,85 9,61 9,98 9,72 9,91
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:00EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEAmicus Therapeutics Announces First Quarter 2024 Financial..
08/5/202413:00GLOBEAmicus Therapeutics to Present at the Bank of America 2024..
01/5/202413:00GLOBEAmicus Therapeutics to Announce First Quarter 2024 Financial..
20/3/202412:00GLOBEAmicus Therapeutics Issues 2024 Environmental, Social, and..
11/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:35EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202413:00GLOBEAmicus Therapeutics to Present at Upcoming Investor..
28/2/202413:02EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEAmicus Therapeutics Announces Full-Year 2023 Financial..
20/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
15/2/202413:00GLOBEAmicus Therapeutics to Announce Full Year 2023 Financial..
14/2/202422:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202413:00GLOBEAmicus Therapeutics Receives the 2024 New Treatment Award..
06/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
06/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:45EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:44EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:00GLOBEAmicus Therapeutics Announces Presentations and Posters at..
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
18/1/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:25EDGAR2Form 144 - Report of proposed sale of securities
12/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:06EDGAR2Form 144 - Report of proposed sale of securities
10/1/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities
09/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
FOLD
Amicus Therapeutics
EU
FR2CIBFS2926
Credit Agricole CIB FCIA...
LSE
93DN
Sovereign Hsg
EU
MLCHE
Cheops Tech France Eo 10
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés